Aytu Biopharma (AYTU) Current Leases (2019 - 2022)

Aytu Biopharma (AYTU) has 4 years of Current Leases data on file, last reported at $1.2 million in Q1 2022.

• On a quarterly basis, Current Leases changed N/A year-over-year to $1.2 million in Q1 2022; TTM through Mar 2022 was $1.2 million, a N/A change from a year earlier, with the FY2021 full-year figure at $940000.0, up 213.33% from the prior year.
• Current Leases for Q1 2022 stood at $1.2 million, up from $1.2 million in the prior quarter.
• Over the last five years, Current Leases for AYTU reached as high as $1.2 million in Q1 2022 and fell as low as $79362.0 in Q3 2019.
• Historically, Current Leases has averaged $534907.6 across 4 years, with a median of $294619.0 in 2020.
• Across the five-year window, Current Leases gained 21.16% in 2020 and jumped 1069.92% in 2021, its largest moves.
• Year by year, Current Leases stood at $82755.0 in 2019, then climbed by 21.16% to $100263.0 in 2020, then soared by 1069.92% to $1.2 million in 2021, then rose by 2.56% to $1.2 million in 2022.
• Per Business Quant data, the three most recent Current Leases figures were $1.2 million in Q1 2022, $1.2 million in Q4 2021, and $1.1 million in Q3 2021.